Table 3:
Lower-Dose–Reconstruction Configuration | % of the 47 Essential Lesionsb Detected by Readers at Lower-Dose Configurations |
No. of Successful Interpretations per Lower- Dose–Reconstruction Configuration |
JAFROC FOM (95% CI) | |||
---|---|---|---|---|---|---|
2 of 3 | 3 of 3 | Cases with at Least 1 Essential Lesion (n = 34) | Cases without Any Essential Lesions (n = 49) | No. Successful Interpretations (≥71 Required per Design) | ||
200 eff. mAs FBP | 44 (94%) | 39 (83%) | 30 | 48 | 78 | 0.846 (0.78–0.912) |
100 eff. mAs IR | 43 (92%) | 37 (79%) | 29 | 46 | 75 | 0.831 (0.764–0.898) |
100 eff. mAs FBP | 42 (89%) | 36 (77%) | 28 | 45 | 73 | 0.805 (0.732–0.878) |
50 eff. mAs IR | 41 (87%) | 32 (68%) | 26 | 47 | 73 | 0.795 (0.727–0.864) |
50 eff. mAs FBP | 38 (81%) | 31 (66%) | 25 | 47 | 72 | 0.789 (0.717–0.861) |
25 eff. mAs IR | 34 (72%) | 25 (53%) | 22 | 45 | 67c | 0.754 (0.681–0.827) |
The JAFROC FOM for routine unenhanced head CT (250 eff. mAs with IR) was 0.867 (0.805–0.929).
Essential lesions are described in the Materials and Methods. Briefly, they represent lesions correctly localized and classified at the routine dose (250 eff. mAs with IR) by majority of readers.
Dose-reconstruction configuration did not meet preset criteria for agreement with routine-dose interpretation, which was defined as agreement in 71 of the 83 examinations.